Category Archives: Gesundheit/Medizin

Gesundheit/Medizin

Sleep Apnea Devices Market — Global Industry Insights, Outlook Size, Share and Opportunity Analysis, 2017–2025

Sleep apnea is a chronic respiratory sleep disorder that is commonly characterized by disruption of breathing while sleeping. This is characterized by conditions such as shallow periods of breathing or occurrence of breaks and pauses during sleep. The duration pauses can be for a few seconds or can last for several minutes. These disruptive events can occur multiple times during the night. People with loud snoring habits are most vulnerable to sleep apnea. Resumption of breathing after these pauses are mostly followed by choking or snorting sounds. Most people remain undiagnosed of sleep apnea, as it occurs during the night and is difficult to be detected during routine hospital visits. Apnea essentially is the squeezing of air that passes the blockage, while breathing and results in loud snoring. These blockages are mostly encountered in overweight and obese people. People suffering from diabetes are more likely to be victims of sleep apnea. Three major types of sleep apnea are obstructive sleep apnea (OSA), central sleep apnea (CSA) and mixed sleep apnea, which is a combination of the two. Obstructive sleep apnea is the most commonly found form of sleep apnea in which the breathing is interrupted by blockage of airflow.

Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/414

Apart from obesity, various factors such as smoking, hereditary existence, menopause, consumption of medicines with sedative effects, having long neck, alcohol consumption, and improper sleeping habits are also responsible for prevalence of this disorder. Sleep apnea is mainly encountered among the geriatric population with growing levels of obesity. Oventus Inc. suggests that OSA prevails in approximately 3% to 7% of adult men and in 2% to 5% of adult females. In addition to this, 50% of the general population are snorers indicating the fact that this population is potential buyers of the sleep apnea devices. Around 100 million people across the globe are suspected to suffer from OSA in 2014, though the majority of this population remains undiagnosed. Sleep apnea can be treated through multiple treatment options such as natural recovery by changing everyday habits and lifestyle, as well as use of sleep apnea devices such as continuous positive airway pressure (CPAP) devices or wearable forms such as mandibular advancement devices (MAD), position pillows, dental devices or tongue retaining devices. Sleep apnea can also be treated through surgical method in severe cases.

Positive Airway Pressure (PAP) devices:

The global sleep apnea devices can be segmented on the basis of the product type and end users

On the basis of the product type, the global market can be segmented as:

  • Therapeutic devices – These are further sub-segmented as:

  • PAP devices

  • Facial interfaces

  • Oxygen concentrators

  • Adaptive servo- ventilation instruments

  • Airway clearance systems

  • Others

  • Diagnostic devices- These are further sub-segmented as:

  • Polysomnography (PSG) devices

  • Respiratory polygraphs

  • Single channel screening devices

  • Actigraphy systems

    On the basis of the end user, the global market can be segmented as:

  • Hospitals

  • Home Care Settings

  • Sleep Laboratories

  • Others

The North American share to the highest of the sleep apnea devices market

North America dominates the global sleep apnea devices market, followed by Europe and Asia Pacific. High awareness among the populace and favorable reimbursement scenario make North America a key market for sleep apnea devices. Several other factors such as the venture capital funding, the new legislation of PAPs,

Request to viewTable of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/414

Well established presence of multiple sleep apnea in United States of America on global sleep apnea devices market

The company is headquartered in Phoenix, Calif., And is headquartered in Phoenix, Calif. These companies have their products selling over several countries, prominently in the US and Europe, and has established a dominance in the field of sleep in the R & D and distribution force of strong sales. Following are the other players in the global sleep apnea devices market which include SomnoMed Ltd., Weinmann Medical Devices GmbH, Compumedics Ltd., Whole You Inc., BMC Medical Co. Ltd., and Braebon Medical Corporation.

ABOUT US:

Coherent Market Insights is a prominent market research and consulting company offering comprehensive, comprehensive, and market-oriented analysis, consulting, and consulting services

Contact us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
# 3200
Seattle, WA 98154

Tel: + 1-206-701-6702

E-mail: sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com

Gesundheit/Medizin

Bone Growth Stimulator Market — Global Industry Insights and Opportunity Analysis, 2016–2024,

Bone Growth Stimulator Market Overview:

Bone growth stimulators or BGSs are supplemental devices that are worn after a lumbar (low back) or cervical (neck) spine surgery. Bone growth stimulators can be used to assist spinal bone fuse after a failed fusion procedure. Bone growth stimulation for the cervical and lumbar spine has significant benefits after a fusion procedure. Various doctors recommend BGS for post-operative lumbar and cervical cases. A bone growth stimulator sends low intensity electrical signals to the site of fusion. These electrical signals trigger natural bone healing process of the body, which are sometimes impaired in surgery patients. The global demographic scenario is quite diverse. For instance, India is a country with more than half of the population in the youth bracket, whereas China and the U.S. have the maximum geriatric population. Bone growth stimulators have observed an implausible demand in the past few years. The early development of BGS began in the U.S. and the innovation in technology has made developed and sophisticated products to enter the market.

According to the International Osteoporosis Foundation, osteoporosis causes around 8.9 million fractures per year that is around one osteoporotic fracture every 3 seconds. Moreover, osteoporosis is expected to affect around 200 million women worldwide. Around 80%, 75%, 70% and 58% of forearm, humerus, hip and spine fractures, respectively, affects women. A fracture, especially in the spinal cord requires bone surgery. Out of these surgeries, a significant number of patients will need bone growth stimulators due to steady recovery. This in turn will drive the growth of the overall bone growth stimulator market during the forecast period.

Fill the form for an exclusive sample of this report @ https://www.coherentmarketinsights.com/insight/request-sample/225

Bone growth stimulator market Taxonomy

On the basis of the type of product, the global bone growth stimulator market is classified into:

Pulsed Electromagnetic Field (PEMF) Devices

Capacitive Coupling (CC) Devices

Combined Magnetic Field (CMF) Devices

Ultrasound Bone Growth Stimulators Surgical Devices

Invasive Electrical Bone Growth Stimulators

On the basis of the type of application, the global market is classified into:

Trauma injury and fractures

Spinal Fusion

Osteogenesis

Some of the factors are ascending as a result of the growth of the health care sector. Nonetheless, a variety of factors such as uncertainty about efficacy, and availability of alternative therapies may hinder the growth of the overall market.

Request to viewTable of content @ https://www.coherentmarketinsights.com/ongoing-insight/toc/225

Increasing prevalence of vertebral fractures, especially in the geriatric population

According to the International Osteoporosis Foundation, the number of vertebral fractures is 45% in North America and 46% in Latin America. After a surgery for a vertebral fracture, there is a high risk of requiring hospitalization for another fracture in the following years. To decrease the morbidity rates in patients with a history of bone surgeries, bone growth stimulators are used extensively. As the number of cases is increasing at an alarming rate, so is the need for bone growth stimulators. This will stimulate the growth of the global bone growth stimulator.

As per the International Osteoporosis Foundation, white women aged 50 years, at 16% lifetime risk of a vertebral fracture. The staggering percentage of the population with risk of vertebral fracture over the age of 50 will be responsible for increased number of bone surgeries, thereby augmenting the growth of bone growth stimulators. By geography, North America is likely to dominate the bone growth stimulus industry. Western Europe wants to follow North America in terms of market share. Availability of advanced public health systems and subsidies,

Orthodontics, NV, Aetna Inc., Smith & Nephew, Biomet Holdings Inc., Ossatec Benelux BV, Elizur, Bioventus LLC, Orchid Medical, IGEA SpA, and Verve Consulting Inc.

ABOUT US:

Coherent Market Insights is a prominent market research and consulting company offering comprehensive, comprehensive, and market-oriented analysis, consulting, and consulting services

Contact us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
# 3200
Seattle, WA 98154

Tel: + 1-206-701-6702

E-mail: sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com

Gesundheit/Medizin

Pharmacy Automation Market – Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017–2025

Pharmacy automation is a mechanical process where handling and distribution of medications takes place in hospital pharmacy or at retail pharmacy. It includes any pharmacy task that involves counting of small objects such as tablets or capsules, measuring and mixing of powders and liquids for compounding, tracking and updating customer information in databases such as personally identifiable information (PPI), drug interaction risk detection, medical history and inventory management. The pharmacy automation market is expected to favor the growth owing to features such as system integration, which increases the productivity and time to clinicians for patient care.

Fill the form for an exclusive sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/472

Furthermore, demand for pharmaceutical products, technologically advanced robotic equipment and tools to perform operations at faster rate pharmacy automation is required in the near future. Whereas, constant developments in technology favors dispensing of prescription medications safer, more accurate and more efficient. Pharmacy automation has helped to provide improved workflow and efficiency to pharmacist as pharmacy automation can manage over 200-300 medications and patient information in an effective and secure manner. Furthermore, increasing government initiatives to improve healthcare infrastructure in emerging economies such as India and China is in turn expected to fuel growth of the pharmacy automation market.

  • Pharmacy Automation Market Taxonomy

  • By Product Type

  • Automated Medication Dispensing

  • Automated Storage and Retrieval Systems

  • Automated Packaging and Labeling

  • Tabletop Tablet Counter

  • Automated Compounding Devices

  • By End-User

  • Retail Pharmacy

  • Hospital Pharmacy

Increase in need to reduce medication errors fuels the pharmacy automation market

Medication errors such as failure in the drug prescription or dispensing process is lethal to patients, which occurs due to increase in number of customers and work load on pharmacist that encourages the pharmacist to buy pharmacy automation. Whereas pharmacy automation systems in hospital or at retail pharmacy manages, track drug, supplies health information related to patient so that replenishing of only required items is performed. Additionally, pharmacy automation market is expected to gain traction due to its transparent tracking systems as pharmacy automation accurately maintain the record of medications expiry date and physical quantities which helps to reduce the medication error. According to National Coordinating Council for Medication Error Reporting and Prevention (NCC MERP) around 0.1 million people die annually due to medical errors in hospital in 2014.

Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/472

Regional growth engines for pharmacy automation market

Increase in number of drug prescriptions at pharmacies due to growth in aging population in North America and increase in insurance coverage in the U.S. has elevated the burden from healthcare system of the country, which has highlighted that there is need of improvement in management of work, which is possible by using pharmacy automation.

Furthermore, rapid rise in number of patients and demand for quality care is expected to have a positive impact and also increase in technology advancement in healthcare IT infrastructure also boost the pharmacy automation market in Latin America, Middle East, Africa and Asia Pacific.

Key players to support pharmacy automation market

Technological advancement in pharmacy automation systems have improved pharmacy operation which leads to competition in various manufactures to innovate the product. For example Becton Dickinson and Company developed Cato Mediation Workflow software with an optional camera-based visual documentation hardware that provides visual documentation of syringe, vial and IV container information. Key player operating in pharmacy automation market include Baxter International Inc., Cerner Corporation, Becton Dickinson and Company, McKesson Corporation, Swisslog Holdings AG, Capsa Healthcare, ScriptPro LLC, Yuyama Co., Ltd., Omnicell Inc. and Talyst, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Gesundheit/Medizin

Nebulizers Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Nebulizers are drug delivery devices that are used to administer medicines in the form of a mist inhaled into the lungs. This drug delivery method helps in the administration of drugs such as corticosteroids, bronchodilators and anti-inflammatory medications. Nebulizers are mainly used for patients suffering from asthma, cystic fibrosis, chronic obstructive pulmonary disease (COPD) and other respiratory diseases or disorders. It is much comfortable to use than other forms of ingested medicines, as it targets the respiratory area directly, thus reducing side effects and harm to other body organs and cells. Nebulizers are especially used for delivery of drug to breathing passages, reduce bulging of mucous membrane, to reduce irritation caused by pollutants and activate and thin out discharge. These devices are specially developed for adults and children who are not able to handle inhalers.

Get a trending sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/545

The use of nebulizer depends on the illness for which it is designed to treat. Various considerations to be taken care of while using a nebulizer are as follows:

  • The appropriate method of using the nebulizer

  • Ways to keep the nebulizer clean for maximum safety and effectiveness

Nebulizers Market taxonomy:

On the basis of product type, the nebulizers market is classified into:

  • Ultrasonic

  • Pneumatic

  • Mesh

Ultrasonic nebulizers include portable and standalone nebulizers.

Pneumatic nebulizers are further classified into:

  • Breath Actuated nebulizers

  • Vented nebulizers

Also, mesh nebulizers are also further classified into:

  • Static type nebulizers

  • Vibrating type nebulizers

Pneumatic nebulizers hold the major share in nebulizers market due to their ease of handling, efficient design and low cost.

On the basis of end user, the nebulizers market is classified into:

  • Hospitals

  • Clinics

  • Ambulatory Surgical Centers

  • Home Care Settings

Product innovation driving the preference for nebulizers in treating respiratory conditions

The advanced nebulizers that features aerosol drug delivery technology with minimal drug wastage is expected to drive the nebulizers market growth. Patients play a vigorous role in supervising their diseases by choosing for devices that assist them in diagnosis and treatment at the comfort of their own homes. This shift in patient preferences will strengthen the global nebulizer market growth scenario in the near future. Also the rise in respiratory cases form a major factor. According to World Health Organization (WHO), around 15.7 million people were reported with Chronic Obstructive Pulmonary Disease (COPD) in the U.S. in 2016 which showed a significant increase of 6.4% from 2015.

Nebulizers are also for a variety of diagnostic procedures among which the principal one is in diagnosis of lung function and bronchial activities. This has also added to the rise in demand for nebulizers in the market by the professionals for clinical use and monitoring of various associated respiratory disorders.

Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/545

Medical reimbursement supporting the North America nebulizer market growth

There are guidelines laid for nebulizers which facilitates its proper usage. The Centers for Medicare & Medicaid Services, and United HealthCare Services, Inc. have defined guidelines for the proper usage of nebulizers in different respiratory issues. In addition to that there are various reimbursement policies that fuel the growth of the market, for instance, policies by Medicaid & Healthcare Partnership in 2012 helped in the easy purchase of nebulizers. Under Hawaii Medical Service Association, in 2014, several cover plans were made for the easy purchases of small volume and large volume nebulizers.

Also, there exists a rental market for nebulizers that assists the usage of these devices in home care settings.

Since nebulization is a spraying technique, therefore the dispersion and wastage of the drug during delivery to the respiratory tract is one of the major restraint for the growth of nebulizers market. Moreover, low consumer switching cost and availability of alternative therapies increases the threat of substitute products.

By geography, North America holds the major share in the global nebulizers market because of the availability of reimbursement and increasing incidence of respiratory diseases.

Key players in the global nebulizers market are GE Healthcare Ltd, Agilent Technologies, GF Health Products, Philips Healthcare CareFusion Corporation, PARI Respiratory Equipment, Covidien plc and Omron Healthcare Co. The players are undertaking various clinical trials and development activities in an endeavor to improve therapeutic effect of the drug. Theravance Biopharma and Mylan announced the initiation of phase 3 studies of revefenacin at the American Thoracic Society (ATS) International Conference in 2017. Revefenacin is a once-daily long acting muscarinic antagonist (LAMA) nebulized therapy. Development of such drugs intended to be delivered via nebulization will also support propelling the growth for nebulizers market. Also Vectura received FDA approval to start testing a smart technology of nebulizers to improve asthma therapies in children.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Gesundheit/Medizin

Ophthalmic Devices Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Ophthalmology refers to a branch of medical sciences that deals with the structural and functional defects of the eye. Ophthalmic devices are medical devices used in the treatment and identification of certain ocular deformities and deficiencies of the eyes. The global ophthalmic devices market is driven by eye disorders such as glaucoma, diabetic retinopathy, macular degeneration, and cataract and vision care devices. Ophthalmic devices are also used in various surgical processes such as ultrasound phacoemulsification for faster recovery rates and improved safety. A wide range of ophthalmic devices are available in the market from high complexity devices such as phoropters , ophthalmoscopes, retinoscopes and scanning laser polarimetry devices to low end products such as contact lenses, spectacles and lens cleaning and disinfecting solutions, Thus, the demand for ophthalmic devices is anticipated to be increasing significantly over the forecast period.

Get a trending sample of this report : https://www.coherentmarketinsights.com/insight/request-sample/686

Increasing prevalence of eye disorder is projected to fuel growth of the global ophthalmic devices market

According to the International Journal of Advanced Medical and Health Research 2015, cataract has been reported to be the major cause of blindness, affecting 17-18 million people worldwide, accounting for 39% of such cases. Following cataract, glaucoma is seen to be the second major reason causing blindness among people. According to the Glaucoma Research Organization, over 120,000 people are blind due to glaucoma accounting up to 9-12% of total blind cases. These massive numbers are basically the output of eye disorders prevalence in the geriatric population and changing food habits leading to nutritional deficits in the younger population. The ophthalmic devices can be used in order to treat cataract, glaucoma and several other eye disorders that could propel the global ophthalmic devices market.

The vision care devices segment dominating the global ophthalmic devices market in terms of over the counters sales

The global ophthalmic devices market is segmented on the basis of product type, disorder, and geographical region.

On the basis of product type, the global ophthalmic devices market is segmented as

  • Diagnostic and Monitoring Devices

  • Surgical Devices

  • Vision Care Devices

Vision care devices witnesses maximum sale over the counter and therefore accounts for the largest share. Furthermore there is a rapid rise in number of people affected with eye disorders and increasing awareness among the populace about eye health and safety augments growth of the segment. According to The Vision Council, over 87% of people in the U.S. are reported to be using digital devices for over 2 hours per day, thereby developing eye strain, dry eyes, blurred vision, etc. These small eye related troubles can be sorted with the use of vision care devices in turn potentiating the global ophthalmic devices market. Moreover, rapid growth in the eye diseases such as cataract and glaucoma are resulting in potential growth of the surgical devices segment that would be required in the treatment of these disorders.

On the basis of disorders, the global ophthalmic devices market is segmented as

  • Cataract Surgery Devices

  • Refractive Surgery Devices

  • Vision Care

  • Ophthalmic Diagnostic Devices

  • Vitreo Retinal Surgery Devices

  • Glaucoma Surgery Devices

Emerging economies of Asia Pacific to boost global ophthalmic devices market growth in the forecast period

Based on regional segmentation, the global ophthalmic devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East and Africa. The North America is accounted to capture highest share in the global ophthalmic devices market owing to innovation and focus on diagnostic devices and surgery applications as well as higher market penetration levels. The emerging economies such as China, India, Japan and Brazil are estimated to gain an early momentum in the market as a result of massive investments by manufacturers.

Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/686

Governments in developing countries focusing towards eye safety and vision care thereby mushrooming the global ophthalmic devices market

The annual rise in the prevalence of eye disorders such as cataract, glaucoma and macular degeneration are the major drivers of the global ophthalmic devices market. Several other factors that are responsible to bolster the growth of ophthalmic devices market includes advent of technologically advanced minimally invasive surgery, rise in geriatric population and demand for surgical and diagnostic instruments. The growing occurrence of eye disorders in children will also add up to fuel the market growth. The governments in developing countries supporting to establish sophisticated healthcare infrastructure and eye care centers will in turn favor growth of the global ophthalmic devices market. However, the inadequate awareness among the developing nations regarding vision care and treatments related to eye disorders can inhibit the market growth.

The global ophthalmic market is very vast, rapidly growing as well as highly competitive. Some of the major players operating global ophthalmic market are Johnson and Johnson, Novartis AG, Bausch & Lomb Inc., Essilor International, Abbott Laboratories Inc., VisionCare Inc., Hoya Corporation, Canon Inc., Carl Zeiss AG, Topcon Corporation, Nidek Co Ltd., CooperVision AG and Alcon Inc. The players are sustaining their prime position in the global ophthalmic devices market due to consistency in launching of new ophthalmic devices and eye care products. Alongside, several other new entrants may also create growth opportunities and enhance the growth of the global ophthalmic devices market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity

Contact Us:

Mr.Shah

Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154

Tel: +1–206–701–6702

E-mail:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Gesundheit/Medizin

AVA-Fachtagung in Uslar war ein Erfolg: Alle wollen gesunde Kühe

Namhafte Vertreter von Tierzuchtorganisationen, Referenten aus der Praxis, als auch aus wissenschaftlichen Einrichtungen aus Deutschland und Österreich und ausgewiesenen Tierzuchtwissenschaftler diskutierten am letzten Wochenende in Uslar, bei Göttingen, auf einer von der Agrar- und Veterinär- Akademie (AVA) aus dem münsterländischen Horstmar-Leer organisierten Veranstaltung mit praktizierenden Tierärzten und Landwirten zu aktuellen Problemen der modernen Milcherzeugung unter besonderer Beachtung tierzüchterischer Aspekte. Sowohl Unterzeichner der „Göttinger Erklärung 2016“ als auch Unterzeichner der „Stellungnahme der DGfZ zur Göttinger Erklärung 2016 zur Milchproduktion“ brachten sich durch ihre Referate bzw. ihre oft auch lebhaften Diskussionsbeiträge in einen auf Konsens suchenden Dialog vor Ort ein. In der Tat wurden auch zahlreiche Punkte herausgearbeitet, die die Grundlage für ein zukünftig engeres Zusammenrücken aller Beteiligten aus Wissenschaft und Praxis bilden könnten. So bestand Einigkeit darüber, dass ein relativer Gesamt-Zuchtwert (RZ) für Gesundheit (RZGesundheit) dringend angezeigt ist. Alle Referenten und die zahlreichen Diskussionsteilnehmer der AVA-Tagung begrüßten solche Ansätze, die letztendlich  die Gesundheit der Milchkühe verbessern soll. Die AVA-Veranstaltung gab allen Beteiligten die Gelegenheit zu einer offenen und breiten Diskussion der Vor- aber auch Nachteile der modernen Milcherzeugung. Interessant war das große Interesse speziell der Tierärzteschaft aber auch der Beratung, sich über neue Entwicklungen in der Holstein- bzw. Fleckviehzucht zu informieren. Für den Organisator des Fachaustausches, Ernst-Günther Hellwig, Gründer und Leiter der Agrar- und Veterinär- Akademie (AVA) und selbst Fachtierarzt und Agrarwissenschaftler, war es ein Anliegen, die  unterschiedlichen Positionen von Organisationen und der Praxis zum Wohle der Kühe gemeinsam zu diskutieren. Zweifellos wäre es wünschenswert gewesen, wenn noch mehr Verantwortliche aus den Rinderzucht-Verbänden anwesend gewesen wären. Hier haben offensichtlich die Geschäftsführer und ihre Zuchtverantwortlichen noch nicht erkannt, dass es besser ist miteinander als übereinander zu reden. Repräsentanten sowohl der Dachorganisation für die Holstein-Züchter (= der DHV) als auch für das Fleckvieh und Braunvieh (= die ASR) haben eine Chance verpasst, mit interessierten Tierärzten oder auch kritischen Holstein- oder Fleckviehzüchtern ins Gespräch zu kommen. Und wer glaubte, dass nur bei Milchrindern (Holsteins und Brown Swiss) kritische Fragen von Praktikern gestellt wurden, der irrte. Einige neuere Entwicklungen wurden auch beim Zweinutzungsrind ‚Fleckvieh‘ kritisch beleuchtet.

‚Uslar 2.0‘ war eine hervorragende Plattform zum ehrlichen Gedankenaustausch für Tierzüchter und Tierärzte, Praktiker und Wissenschaftler ohne Schuldzuweisung an jeweils den Anderen. Es war das Ziel dieser AVA-Fachtagung, zweifellos noch vorhandene ‚Gräben‘ in der Zuchtzielgestaltung abzubauen und zu überwinden.

Auch die sehr harte Kritik von Landwirtin Frau Kirsten Wosnitza, praktische Milchbäuerin aus Norderfeld (Schleswig-Holstein), an den Siegertieren auf den aktuellen Holstein-Schauen oder von Herrn Dr. Thomas. Grupp, Bayern-Genetik, an die zunehmende ‚Papier-Genetik‘ in der Fleckviehzucht fanden ihre Zustimmung unter fast allen beteiligten Diskussionspartnern. Natürlich fanden auch Beiträge zu den „CO2 footprints“ der Milchkühe Beachtung, wird dies doch zunehmend von den Verbrauchern kritisch gesehen. Der Beitrag der Tierärztin Dr. Anita Idel, Buchautorin des Buches „Die Kuh ist kein Klimakiller“ fand erhebliche Beachtung unter den Fachleuten.  „Uslar 2.0“ war eine erfolgreiche Fachtagung.

 

 

 

 

Weitere Informationen über die Agrar- und Veterinär-Akademie(AVA) findet man auf der AVA-Homepage unter: www.ava1.de

 

Zur Information: Die AVA ist eine Fortbildungsgesellschaft mit dem Ziel der Aus- und Weiterbildung und der Verteilung von Informationen für den landwirtschaftlichen und tiermedizinischen Bereich. Gleichzeitig ist die AVA ein Forum für Landwirte und Tierärzte, das die Herausforderungen der Produktion gesunder Nahrungsmittel in den nächsten Jahrzehnten in den Blick nimmt.

»Ziel der Agrar- und Veterinär-Akademie ist es, die Probleme der modernen, nachhaltigen Landwirtschaft und Tierhaltung zu erörtern. Wir wollen gemeinsam Wege finden, um tiergerecht, praxisbezogen und verbraucherorientiert zu arbeiten« Ernst-Günther Hellwig, Gründer und Leiter der AVA, Horstmar-Leer

 

Ernst-Günther Hellwig

Agrar- und Veterinär-Akademie (AVA) EG Hellwig

Dorfstraße 5  –  D 48612 Horstmar-Leer

fon: +49-(0)2551- 7878   fax: +49-(0)2551-83 43 00

info@ava1.de       www.ava1.de

 

 

 

 

 

Gesundheit/Medizin

Solid Tumors Treatment Market – Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

A solid tumor is an abnormal mass or lump of tissues without liquid or cysts. It is not necessary that tumor should always be cancerous. On the basis tumor nature, it can be classified as the malignant tumor (cancerous) and the benign tumor (non-cancerous). Based on the cell type, tumors can be classified as carcinomas, sarcomas, and lymphomas. The Solid tumors might occur in several places such as muscle, bone, and organs. Treatments for solid tumors include prevention of tumor and combination of surgery, chemotherapy, and radiation therapy. However, new forms of treatment are emerging in the market.

Fill the form for an exclusive sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/793

Emerging trend of Biosimilars therapy is expected to propel the growth of solid tumors treatment market

According to data published in International Journal of Pharma Sciences and Research (IJPSR) in 2011, there were around 9 million deaths due to cancer. In 2015, 11.4 million people are expected to die in 2030, among this prevalence of cancer maximum is due to solid tumors. Growing prevalence of solid tumors is the major driving factor for the growth of solid tumors treatment market. Additionally, some other factors fuelling the growth of solid tumors treatment market include unmet demand for cancer treatment and rising investment in the research and development of cancer drugs.  However, increase in the volume of generic therapeutic products, the high cost of cancer therapy, and growing drug patent cliff are some of the restraints that might hinder the growth of solid tumors treatment market.

Moreover, the emerging trend of biosimilars is contributing to the growth of solid tumors treatment market due to their low cost and their similarity to originator compound. For instance, some of the biologics available for solid tumors treatment includes Herceptin, MabThera, Avastin, and Erbitux. The advantages of this biosimilars to overcome the limitations of generic drugs in the treatments is expected to propel the growth of solid tumors treatments market.

Chemotherapy segment holds the maximum share in solid tumor treatment market due to its efficacy by combining with some other therapies to treat solid tumors.

The global solid tumors treatment market is segmented by therapy, by application, by the end user, and by region.

On the basis of therapy, solid tumors treatment market is segmented into

  • Radiotherapy

  • Chemotherapy

  • Immunotherapy

  • Hormone therapy

  • Targeted therapy

On the basis of application, solid tumors treatment market is segmented into

  • Lung cancer

  • Breast cancer

  • Prostate cancer

  • Cervical cancer

  • Colorectal cancer

  • others

On the basis of end users, solid tumors treatment market is segmented into

  • Hospitals

  • Cancer treatment centers

Rising incidences of solid tumor cases in North America is the factor contributing to the growth of solid tumor treatment market

Regional segmentation of Solid Tumors Treatment market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Africa, and the Middle East. North America dominates in the solid tumors treatment market due to the presence of well-established healthcare infrastructure, and rise in the number of solid tumor cases. For instance, According to the data provided by Centers for Disease Control and Prevention (CDC) in 2013 around 230,815 females and 2109 men in the U.S. were diagnosed with breast cancer. Asia Pacific is expected to grow in the solid tumors market due to the increase in healthcare expenditure, rising patient population, medical tourism, and increasing affordability of people in this region.

Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/793

Advanced drug therapy is expected to help the industry players to sustain in the solid tumors treatment market

Key industry players operating solid tumors treatment market include Abbott Laboratories Inc., Biogen Idec Incorporated, AstraZeneca Plc., Johnson & Johnson Company, Amgen Inc., Bristol Myers Squibb Company, GlaxoSmithKline Plc., Sanofi, and Baxter International Incorporated. Advancements in the cancer therapy such as nanomedicines used for the treatment of cancer might help the industry players to provide effective patient care in the solid tumors treatment. Whereas, stringent regulatory policies for drug manufacturing may restrain the growth of the market. For instance, by regulations provided by the Indian government in late 2012, there are cap prices of 348 drugs on Essential Drug List (EDL), and drug manufacturers need to keep the cost of their drugs below the ceiling price.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Gesundheit/Medizin

Biopreservation Market — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Biopreservation is the technique used to increase shelf life of product, and to ensure the stability, purity of bio specimens. Bio-preservation is used for the storage of cells, tissues, organs and its recent trend includes its use in food safety. The equipment such as refrigerators, liquid nitrogen and consumables, and media and laboratory information management systems are used for bio preservation. Biobanking is a type of biopreservation that is widely used in medical research such as genomics research and for personalized medicine. Numerous type of bio specimen like saliva, plasma, and purified DNA can be maintained through biopreservation technique and maintain safe from contaminants. Some samples can be stored for longer time with the help of biopreservation so that it can be used for longer research studies.

Fill the form for an exclusive sample of this report:https://www.coherentmarketinsights.com/insight/request-sample/748

Increase in government initiatives to boost the research and development is driving the growth of biopreservation market

Increase in number of human sperm and egg banks, and rising demand for preservation of new born stem cells, and adoption of in- house sample storage in hospitals are some of the major factors driving the growth of biopreservation market. Government initiatives in the form of grants, funds, and contract or other type of funding will boost the research and development activities for various companies and research organizations is expected to boost the market. For Instance, according to UK government policy, 2015 explains that there is an expected investment of £5 billion in health and research development by 2020 and additionally Welcome Trust (WT) UK is going to provide funds around £13.9 billion in healthcare research.

Increase in healthcare expenditure globally, investment in bio-banks and personalized medicines, are also propelling the biopreservation market growth. The rising population with lifestyle related diseases, cardiovascular diseases, cancer and hypertension are other factors that are driving the growth of biopreservation market. According to World Health Organization (WHO), in 2015, cardiovascular diseases caused 31% of all diseases and 8.8 million people died due to cancer. However, there are certain restraints effecting the market which includes chances of tissue injury during the preservation, high cost of instruments and their maintenance. The technological breakthroughs and regenerative drugs along with the applications of biobanking for cell, tissue, and organ is expected to create numerous opportunities in the biopreservation market.

Bio-banking segment dominates the biopreservation market due its extensive application in numerous areas

The global biopreservation market is segmented by application, by product type, by bio–specimens, by end user and by region.

On the basis of application, the market is segmented into

  • Bio banking

  • Human eggs

  • Human sperms

  • Veterinary IVF

  • Regenerative medicine

  • Cell therapy

  • Gene therapy

  • Drug discovery

On the basis of product type, the market is segmented into

  • Vials

  • Straws

  • Bags

  • Microtiter plates

  • Equipment

  • Freezers

  • Refrigerators

  • Consumables

  • Others

On the basis of bio–specimens, the market is segmented into

  • Tissue samples

  • Stem cells

  • Organs

  • Others

On the basis of end users, the market is segmented into

  • Bio banks

  • Hospitals

  • Research organizations

  • Others

Request for table of content : https://www.coherentmarketinsights.com/ongoing-insight/toc/748

Biopreservation market is expected to show a sustainable growth in Asia Pacific due to the increase in awareness about preservation of umbilical cord cells

Regional segmentation of global biopreservation market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Middle East and Africa. North America dominates the biopreservation market owing to the factors such as development of novel drugs, increasing demand for diagnosis of chronic diseases, therapies in healthcare sector, and regulations by government to support ethical usage of biological samples. Biopreservation market is driven in the Asia Pacific region due to some factors such as rising population, rise in investments in healthcare research, and growing awareness about preservation of umbilical cord cells. The statistics published in New England Journal of Medicines informed that in 2012, Japan and China had increased their total medical research spending by U.S. $9.0 billion and U.S. $6.4 billion respectively and contributed as 13.8% and 3.1% of world’s total medical research expenditure.

Broad product portfolio of major industries helping them to lead in the biopreservation market

Key players operating the market are Biolife solutions, THERMO- FISHER SCIENTIFIC, BioCision LLC, Simport scientific, Cesca Therapeutics, Atlanta biologics, Lifeline scientific, LabVantage solutions, Hamilton Company, Core dynamics ltd., and others. The major industry players are leading in the biopreservation market due to their broad product portfolio particularly related to media, freezers, refrigerators, consumables and their wide regional presence.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email:sales@coherentmarketinsights.com

Website:https://www.coherentmarketinsights.com

Aktuelle Nachrichten Bücher/Zeitschriften Gesundheit/Medizin Pressemitteilungen Rat und Hilfe

Die Stille ist der Raum, in dem die Seele Ruhe und Besinnung findet

Viele Menschen haben Angst vor sich selbst, haben Angst mit sich alleine zu sein, dabei ist die Stille ein ganz wichtiger Teil Ihres Lebens. Die Stille ist der Raum, in dem die Seele Ruhe und Besinnung findet. In der Stille findet die Seele den Abstand von anstrengenden Forderungen und der hektischen Zeit. Die Stille gibt Ihnen Ihre Energie, Lebensfreude, Ausgeglichenheit, Gelassenheit und Kreativität wieder zurück. Man braucht kein Eremit zu sein, um sich mit Meditation zu beschäftigen.

 

Buchautorinnen „Sabine Beuke und Jutta Schütz“ empfehlen täglich 10 – 15 Minuten zu meditieren.

Dafür brauchen Sie keinen teuren Kurs oder Seminare zu belegen – es geht ganz einfach: Legen Sie sich ganz bequem auf eine Decke oder finden Sie eine entspannte Körperhaltung und schließen die Augen. Beginnen Sie ruhig und entspannt zu Atmen und denken Sie, dass Sie nun Ihre Gedanken fließen lassen. Sie werden am Anfang von Ihren Gedanken überflutet werden, das wird sich aber schnell legen.

Eine regelmäßige Meditation kann beruhigend auf die Seele und Körper wirken.

Die Wirkung ist neurologisch als Veränderung der Hirnwellen messbar und auch der Herzschlag wird verlangsamt. Meditation bedeutet: nachdenken, überlegen und heilen.

Durch die Achtsamkeits- oder Konzentrationsübungen soll sich die Seele beruhigen.

In der östlichen Kultur gilt das Meditieren als eine grundlegende und zentrale Bewusstseinserweiterung.

Es gibt viele Meditationstechniken und sie unterscheiden sich nach ihrer traditionellen religiösen Herkunft. Seit den 70er Jahren werden neben den traditionellen Meditationsformen auch an westliche Bedürfnisse angepasste Formen angeboten. Wie wir schon erwähnt haben, wirkt die Meditation am besten, wenn Sie täglich zirka 10 Minuten damit entspannen. Auf Dauer kann man die Zeit der Meditation auf zirka 30 Minuten steigern.

Die besten Zeiten sind früh am Morgen und spät am Abend, wenn die geistige Schwingung am ruhigsten ist. Natürlich können Sie auch zu jedem anderen Zeitpunkt meditieren. Setzen Sie sich in eine bequeme Stellung mit geradem Rücken. Den Rücken nicht an die Wand lehnen. Die Hände liegen dabei auf den Knien oder den Oberschenkeln, Handflächen nach unten (oder nach oben). Bitten Sie Ihre Seele zur Ruhe zu kommen, sich zu erholen und achten Sie dabei auf Ihre Atmung. Sie brauchen einfach nur zu denken, dass Sie sich nun von Ihren Sorgen, Ihrem Kummer, Ihren Ängsten, Ihrem Stress, erholen möchten.

Forscher um Yi-Yuan Tang von der Texas Tech University in Lubbock berichten, dass eine Aufmerksamkeitsmeditation in vier Wochen die Nervenfasern einer bestimmten Gehirnregion stärker als eine reine Entspannungsübung verändert. Nach dem Meditationstraining hat sich in einem vorderen Teil der Hirnrinde die Isolierung der Nervenzellfortsätze (Axone) deutlich verbessert, was zu einer schnelleren Durchleitung von Signalen führt. Dieser sogenannte anteriore singuläre Cortex wird allgemein mit der Kontrolle von Wahrnehmung und Emotionen in Verbindung gebracht sowie mit der Fähigkeit, Konflikte zu lösen.

Das heißt, dass durch die Meditation bereits nach vier Wochen das Gehirn schnellere Signale zeigt und die Forscher sehen darin die Chance für neue Therapien von psychischen Erkrankungen. Wir möchten auch behaupten, dass man auch anders meditieren kann. Wir auf jeden Fall finden verschiedene Situationen, bei denen wir sehr gut entspannen können. Zum Beispiel: mit dem Rad durch die Natur radeln, schwimmen gehen und sich im Wasser vor sich hin treiben lassen, im Sprudelbad sitzen und die Wallungen an der Haut spüren, in einem Straßenkaffee sitzen und Leute beobachten, leichte Musik oder Meeresrauschen von einer CD oder MP3 Player hören und dabei die Augen schließen und träumen.

Versuchen Sie doch auch mal etwas zu tun, was Sie sonst selten machen oder noch nie getan haben. Malen Sie ein Bild, auch wenn Sie denken, Sie können nicht malen oder dekorieren Sie Ihre Wohnung neu. Visuelle Reize regen unsere Kreativität an und lenken uns vom Alltag ab.

Kennen Sie den Spruch von Jacques Rousseau? Der Geruchsinn ist der Sinn der Erinnerung und des Verlangens. Auch Düfte regen unsere Sinne an und jeder Duft gelangt über die Nase in bestimmte Teile des Gehirns. Der Duft stimuliert in Sekundenschnelle das vegetative Nervensystem. Die Gerüche setzen sich aus bis zu 500 Einzelwirkstoffen zusammen und es reichen oft nur wenige Substanzen, um einen Geruch zu erkennen.

Dem Vanillearoma sagt man zum Beispiel nach, dass es ein Glücksbote sei. Der süße Duft setzt Glückshormone frei und es hat eine positive Wirkung auf unsere Gedankenwelt. Rosenöl sorgt für gute Laune und Lavendel ist ein Schlummerkraut, das für eine ausgeglichene Wirkung sorgen kann. Der eingeatmete Duft gelangt durch die Nase auf unsere Riechschleimhaut. Dort sitzen zirka 10 Millionen Riechnervenzellen, wo jede Riechzelle auf einen speziellen Duftstoff spezialisiert ist.

Die Düfte wecken Erinnerungen in uns und einige Gerüche versetzen uns zurück in unsere Kindheit. Gefährliche Düfte wie z. B. Modergeruch oder Brandgeruch warnen uns ein Leben lang. Dagegen bleiben uns die Düfte, mit denen uns ein schönes Ereignis verbindet, in guter Erinnerung.

 

  • PSYCHOLOGIE KURZ UND KNAPP VERPACKT – Hilfreiches Wissen für die Seele

Autoren: Sabine Beuke und Jutta Schütz

Verlag: Books on Demand – EUR 13,90

ISBN-13: 9783732234929 – ISBN-10: 3732234924

  1. Auflage

 

Diese Presse darf ausschließlich zu informativen, persönlichen und NICHT-kommerziellen Zwecken verwendet werden. Sie dürfen diese Presse ansehen, drucken, kopieren und weitergeben unter folgenden Bedingungen: Die Presse darf nur verwendet werden für den persönlichen, nicht kommerziellen Gebrauch. Die Presse muss bei einer Kopie oder bei einem Teilausschnitt alle rechtlichen Informationen wie das Originaldokument sowie auch das Copyright-Recht „© 2017 Jutta Schütz“ enthalten. Das Werk, einschließlich seiner Teile, ist urheberrechtlich geschützt.

 

Firmeninformation:

Jutta Schütz schreibt Bücher, die anspornen, motivieren und spezielles Insiderwissen liefern. Die Autorin hat bis heute über 75 Bücher geschrieben und an vielen anderen Büchern mitgewirkt. Zudem hilft sie als Mentorin und Coach Neuautoren bei der Veröffentlichung ihrer Bücher und ist in der „Die Gruppe 48 (Deutschsprachige Schriftsteller und Literaturkenner)“ Mitglied und Funktionsträger. Als Journalistin schreibt Schütz für Verlage und Zeitungen. Ihre Themen sind: Gesundheit, Psychologie, Kunst, Literatur, Musik, Film, Bühne, Entertainment. Weitere Informationen zur Autorin und ihren Büchern findet man in den Verlagen, auf ihrer Webseite – sowie im Kultur-Netzwerk.

 

Pressekontakt:

Jutta Schütz

Achenkamp 0

D-33611 Bielefeld

info.schuetz09@googlemail.com

www.jutta-schuetz-autorin.de/

www.die-gruppe-48.net

Aktuelle Nachrichten Bücher/Zeitschriften Essen/Trinken Gesundheit/Medizin Pressemitteilungen

Low Carb Fingerfood

Früher nannte man dieses Essen „Imbiss“, heute heißt es Fingerfood.

30 kohlenhydratarme (Low Carb) Rezepte.

 

Fingerfood ist ein Trend, der aus den USA stammt und sich bei uns mehr und mehr etabliert. Der Begriff stammt aus dem Englischen und bedeutet „Finger Essen“.

Auf einer Party, Veranstaltungen, Versammlungen, Vereinstreffen oder Umtrunk im Büro, findet die eigenwillige Esskultur immer mehr Zuspruch. Die kleinen Häppchen passen zu fast allen Gelegenheiten und machen Eindruck bei den Gästen.

Eine kohlenhydratarme Ernährung (Low Carb) korrigiert den gestörten Stoffwechsel und hilft das Übergewicht zu verringern. Der Blutzucker wird durch diese Ernährungsweise stabilisiert und entlastet den Körper in vielen Bereichen.

 

  • Low Carb Fingerfood

Die kohlenhydratarme Küche

Autorin: Jutta Schütz

Verlag: Books on Demand

Paperback – ISBN-13: 978-3-7448-3411-7

Erscheinungsdatum: 09.06.2017 – Sprache: Deutsch – 3,99 €

Auch als E-Book erhältlich

 

Diese Presse darf ausschließlich zu informativen, persönlichen und NICHT-kommerziellen Zwecken verwendet werden. Sie dürfen diese Presse ansehen, drucken, kopieren und weitergeben unter folgenden Bedingungen: Die Presse darf nur verwendet werden für den persönlichen, nicht kommerziellen Gebrauch. Die Presse muss bei einer Kopie oder bei einem Teilausschnitt alle rechtlichen Informationen wie das Originaldokument sowie auch das Copyright-Recht „© 2017 Jutta Schütz“ enthalten. Das Werk, einschließlich seiner Teile, ist urheberrechtlich geschützt.

 

Firmeninformation:

Jutta Schütz schreibt Bücher, die anspornen, motivieren und spezielles Insiderwissen liefern. Die Autorin hat bis heute über 75 Bücher geschrieben und an vielen anderen Büchern mitgewirkt. Zudem hilft sie als Mentorin und Coach Neuautoren bei der Veröffentlichung ihrer Bücher und ist in der „Die Gruppe 48 (Deutschsprachige Schriftsteller und Literaturkenner)“ Mitglied und Funktionsträger. Als Journalistin schreibt Schütz für Verlage und Zeitungen. Ihre Themen sind: Gesundheit, Psychologie, Kunst, Literatur, Musik, Film, Bühne, Entertainment. Weitere Informationen zur Autorin und ihren Büchern findet man in den Verlagen, auf ihrer Webseite – sowie im Kultur-Netzwerk.

 

Pressekontakt:

Jutta Schütz

Achenkamp 0

D-33611 Bielefeld

info.schuetz09@googlemail.com

www.jutta-schuetz-autorin.de/

www.die-gruppe-48.net